A French start-up company plans to revolutionize the treatment of age-related macular degeneration (AMD) with a new generation retinal implant.
160 million people worldwide are affected by dry AMD. 2-5% of all Dry-AMD is Geographic Atrophy which there is currently no treatment available. During the « Journées nationales de la macula » November 23rd to 27th, 2020, Pleine Vie dedicates a piece to Pixium Vision and its Prima system.
Pixium Vision’s key opinion leader on the Prima System for Atrophic Dry Age-related Macular Degeneration (dry-AMD). In case you were unable to attend or would like to hear all or part of it again, the replay of the event is now available online: https://www.pixium-vision.com/KOL-Call-October-2020/
The webinar featured a presentation by José-Alain Sahel, M.D., University of Pittsburgh School of Medicine, Lisa C. Olmos de Koo, M.D., University of Washington and Ralf Hornig, Director of Clinical Affairs, who discussed the current treatment landscape and unmet medical need of Advanced Atrophic dry-AMD. They also shared their experience on how the Prima system is helping their patients regain autonomy and quality of life. Dr Yannick Le Mer and Dr Joseph Martel joined to answer questions following the formal presentation.The Pixium Vision management team also gave an update on the Prima System which has the potential to address this significant unmet medical need in dry-AMD.
Alexandra Rocher has more than 20 years of experience in the development, validation and improvement of manufacturing processes, including 15 years in the medical device industry.
First as a production manager at Photonetics on Mux/Demux DWDM for Telecoms.
Then on the certification and transfer to production of IR thermal imaging cameras and binoculars in the Defense and Security sector at SAFRAN,
In 2008, she joined the R&D team of Maunakea Technologies to work on the Cellvizio Confocal Miniprobes, then became Industrialization and Methods Manager in 2016, to coordinate the production transfer activities of the new generations of products, as well as the continuous improvement on the existing production lines.
Brian grew up in Luxembourg and studied mechanical engineering in Switzerland (ETH Zurich) and Boston, U.S.A. (MIT). He has worked on liver perfusion (Wyss Zurich, CH) and the structural heart (CorWave, FR & Alluent Medical, FR), before turning his attention to the eye at Pixium Vision.
Over the last 15+ years he has established a proven track record of bringing the most ambitious projects from the drawing board to viable products.
Offer Nonhoff has more than 20 years in leading finance functions across various industries in emerging companies with disruptive technologies and large corporate enterprises. Before joining Pixium, Offer spent 2 years as CFO of Trigo Vision, a leading startup in the retail tech space based in Israel, helping the founders achieve commercial readiness while raising material capital. Prior to Trigo he worked 3 years as CFO of Fresenius Medical Care integrating a large Israeli dialysis clinic chain into corporate structures. During his 5 years at BONESUPPORT he was able to lead the company as CFO from the early stages of commercialization, through hyper growth all the way until IPO. Before that Offer was the CFO of the EMEA Headquarters of Lumenis. Offer started his career working for more than 15 years at Siemens, beginning in the accounting department in Germany until becoming the co-founder of Siemens in Israel and spending 12 years building a multi-million-dollar franchise. Born and raised in Berlin, Offer studied in Germany and the USA receiving his BA of industrial Business Administration from the IHK in Munich